- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03557645
Ventilator Hyperinflation and Hemodynamics (VHI-HD)
Hemodynamic Repercussions of Ventilator Hyperinflation Using Volume-controlled Ventilation: a Randomized Controlled Trial
Study Overview
Status
Conditions
Detailed Description
Background: ventilator hyperinflation (VHI) has been shown to be effective in improving respiratory mechanics, secretion removal, and gas exchange in mechanically ventilated patients; however, the literature is scarce concerning its safety and adverse effects. Thus, the aim of this study is to compare the hemodynamic repercussions of VHI in volume-controlled mode.
Methods: in a randomized, controlled and crossover design, 24 mechanically ventilated patients will undergo 2 modes of ventilator hyperinflation (with and without an inspiratory pause of 2 seconds) and a control intervention. For the VHI interventions, the inspiratory flow will be set at 20 Lpm, and tidal volume will be increased until a peak pressure of 40cmH2O is achieved. During the control intervention, the patients will remain in volume-control ventilation with an inspiratory flow = 60Lpm and tidal volume = 6mL/IBW. The interval between interventions (washout) will be of 10 minutes or more, according to the time needed to recover the cardiac index to baseline values (maximum difference of 10%). Cardiac output, cardiac index, mean arterial pressure, pulmonary vascular resistance, systolic volume and other hemodynamic variables will be recorded during the interventions by using impedance cardiography.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Rio De Janeiro
-
Niterói, Rio De Janeiro, Brazil, 24241-002
- Hospital Santa Martha
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Patients under mechanical ventilation for more than 48h
Exclusion Criteria:
- mucus hypersecretion (defined as the need for suctioning < 2-h intervals),
- absence of respiratory drive,
- atelectasis,
- severe bronchospasm,
- positive end expiratory pressure > 10cmH2O,
- PaO2-FiO2 relationship < 150,
- mean arterial pressure < 60mmHg,
- inotrope requirement equivalent to >15 ml/h total of adrenaline and noradrenalin,
- intracranial pressure > 20mmHg
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Sham Comparator: Baseline Mechanical Ventilation
The subjects will be kept in Volume Control Continuous Mandatory Ventilation (VC-CMV) with an inspiratory flow = 60Lpm and tidal volume = 6mL/IBW.
Positive end-expiratory pressure and the inspired oxygen fraction will not be modified.
|
The subjects will be kept in Volume Control Continuous Mandatory Ventilation (VC-CMV).
|
|
Experimental: VHI With Inspiratory Pause
Application of a ventilator hyperinflation intervention with Volume Control Continuous Mandatory Ventilation (VC-CMV).
The inspiratory flow will be set at 20Lpm, the tidal volume will be increased in steps of 200mL until the peak airway pressure of 40cmH2O is achieved, and an inspiratory pause will be applied at the end of inspiration.
After achieving the target pressure, this ventilatory regimen will last 15 minutes.
Positive end-expiratory pressure and the inspired oxygen fraction will not be modified.
|
Application of a ventilator hyperinflation intervention with Volume Control Continuous Mandatory Ventilation (VC-CMV) with an inspiratory pause.
|
|
Experimental: VHI Without Inspiratory Pause
Application of a ventilator hyperinflation intervention with Volume Control Continuous Mandatory Ventilation (VC-CMV).
The inspiratory flow will be set at 20Lpm and the tidal volume will be increased in steps of 200mL until the peak airway pressure of 40cmH2O is achieved.
After achieving the target pressure, this ventilatory regimen will last 15 minutes.
Positive end-expiratory pressure and the inspired oxygen fraction will not be modified.
|
Application of a ventilator hyperinflation intervention with Volume Control Continuous Mandatory Ventilation (VC-CMV) without an inspiratory pause.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in Cardiac Output
Time Frame: Baseline (before) and 10 minutes after the onset of VHI modesBasel
|
Estimation of cardiac output variation using thoracic bioimpedance
|
Baseline (before) and 10 minutes after the onset of VHI modesBasel
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in Cardiac Index
Time Frame: Baseline (before) and 10 minutes after the onset of VHI modes
|
Estimation of cardiac index variation using thoracic bioimpedance
|
Baseline (before) and 10 minutes after the onset of VHI modes
|
|
Change in Vascular pulmonary resistance
Time Frame: Baseline (before) and 10 minutes after the onset of VHI modes
|
Estimation of vascular pulmonary resistance variation using thoracic bioimpedance
|
Baseline (before) and 10 minutes after the onset of VHI modes
|
|
Change in Systolic Volume
Time Frame: Baseline (before) and 10 minutes after the onset of VHI modes
|
Estimation of systolic volume variation using thoracic bioimpedance
|
Baseline (before) and 10 minutes after the onset of VHI modes
|
|
Change in Mean Arterial Pressure
Time Frame: Baseline (before) and 10 minutes after the onset of VHI modes
|
Recording of mean arterial pressure variation using an automatic noninvasive device
|
Baseline (before) and 10 minutes after the onset of VHI modes
|
|
Change in Cardiac Output II
Time Frame: Baseline (before) and 5 minutes after the end of VHI modes
|
Estimation of cardiac output variation using thoracic bioimpedance
|
Baseline (before) and 5 minutes after the end of VHI modes
|
|
Change in Cardiac Index II
Time Frame: Baseline (before) and 5 minutes after the end of VHI modes
|
Estimation of cardiac index variation using thoracic bioimpedance
|
Baseline (before) and 5 minutes after the end of VHI modes
|
|
Change in Vascular pulmonary resistance II
Time Frame: Baseline (before) and 5 minutes after the end of VHI modes
|
Estimation of vascular pulmonary resistance variation using thoracic bioimpedance
|
Baseline (before) and 5 minutes after the end of VHI modes
|
|
Change in Systolic Volume II
Time Frame: Baseline (before) and 5 minutes after the end of VHI modes
|
Estimation of systolic volume variation using thoracic bioimpedance
|
Baseline (before) and 5 minutes after the end of VHI modes
|
|
Change in Mean Arterial Pressure II
Time Frame: Baseline (before) and 5 minutes after the end of VHI modes
|
Recording of mean arterial pressure variation using an automatic noninvasive device
|
Baseline (before) and 5 minutes after the end of VHI modes
|
Collaborators and Investigators
Collaborators
Investigators
- Study Chair: Fernando Guimaraes, PhD, Centro Universitário Augusto Motta
Publications and helpful links
General Publications
- Lemes DA, Zin WA, Guimaraes FS. Hyperinflation using pressure support ventilation improves secretion clearance and respiratory mechanics in ventilated patients with pulmonary infection: a randomised crossover trial. Aust J Physiother. 2009;55(4):249-54. doi: 10.1016/s0004-9514(09)70004-2.
- Berney S, Denehy L. A comparison of the effects of manual and ventilator hyperinflation on static lung compliance and sputum production in intubated and ventilated intensive care patients. Physiother Res Int. 2002;7(2):100-8. doi: 10.1002/pri.246.
- Anderson A, Alexanders J, Sinani C, Hayes S, Fogarty M. Effects of ventilator vs manual hyperinflation in adults receiving mechanical ventilation: a systematic review of randomised clinical trials. Physiotherapy. 2015 Jun;101(2):103-10. doi: 10.1016/j.physio.2014.07.006. Epub 2014 Oct 6.
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- VHI Hemodynamics
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Respiratory Failure
-
University Hospital, Strasbourg, FranceRecruitingRespiratory Failure | Cardiac FailureFrance
-
Hemovent GmbHseleon GmbHRecruitingRespiratory Failure | Cardiac Failure | Cardio-Respiratory Failure | Imminent Cardiorespiratory or Respiratory FailureGermany
-
Catholic University of the Sacred HeartFisher and Paykel HealthcareCompletedWeaning Failure | Acute Respiratory FailureFrance, Greece, Italy, Spain
-
Efficacy Care R&D LtdMemorial Hermann Hospital; CRG Medical, Inc.UnknownShock | Shock, Septic | Respiratory Failure | Respiratory Distress Syndrome | Shock, Cardiogenic | Acute Cardiac Failure | Acute Respiratory Failure | Acute Kidney Failure | Multi Organ Failure | Respiratory Arrest | Acute Respiratory Failure With Hypoxia | Acute Respiratory Failure Requiring Reintubation | Acute... and other conditionsUnited States
-
Hospital Clinic of BarcelonaCompletedHypercapnic Respiratory Failure | Hypoxemic Respiratory FailureSpain
-
UPECLIN HC FM Botucatu UnespUnknownExtubation Failure | Acute Respiratory Failure Post ExtubationBrazil
-
University of OsloOslo University HospitalCompletedHypercapnic Respiratory Failure | Type 2 Respiratory FailureNorway
-
Hospital Sao JoaoCompletedVentilatory Failure | Post-extubation Failure | Persistent Weaning Failure | Secretion Encumbrance | Weak CoughPortugal
-
Fisher and Paykel HealthcareCentre hospitalier de l'Université de Montréal (CHUM); Institut universitaire...RecruitingAcute Hypoxemic Respiratory Failure | Acute Hypercapnic Respiratory FailureCanada
-
Siriraj HospitalCompletedAcute Hypoxemic Respiratory Failure | Acute Hypercapnic Respiratory FailureThailand
Clinical Trials on Baseline Mechanical Ventilation
-
Peking Union Medical College HospitalThe First Affiliated Hospital with Nanjing Medical University; National Natural... and other collaboratorsUnknownAcute Respiratory Failure | Immunocompromised Patients
-
Ruijin HospitalUnknownAcute Pancreatitis | Complication of Ventilation TherapyChina
-
Riphah International UniversityCompletedBurns (Physical Finding)Pakistan
-
Limin ZhuUnknownRight Ventricular Hypertrophy | Congenital Heart Disease | Postoperative Care | Mechanical Ventilation | Heart-lung InteractionChina
-
Karolinska InstitutetCompleted
-
Seoul National University HospitalCompletedVentilation | Out-Of-Hospital Cardiac Arrest | Advanced Cardiac Life SupportKorea, Republic of
-
Beijing Sanbo Brain HospitalRecruiting
-
University of Roma La SapienzaRecruiting
-
Bakirkoy Dr. Sadi Konuk Research and Training HospitalRecruitingCOVID-19 Pneumonia | COVID-19 Acute Respiratory Distress SyndromeTurkey
-
Beijing Chao Yang HospitalCompletedInterstitial Lung Disease | Risk Factors | Morality | Mechanical Ventilation